Postgraduate Year Two (PGY2) Oncology
The PGY2 Oncology Residency at Nebraska Medicine offers a unique and stimulating learning environment which provides comprehensive clinical training in hematology and oncology pharmacy practice. The goal of the residency program is to develop clinical practitioners who specialize in the care of oncology patients and also have an interest in education and research. After orientation, residents will participate in ten months of clinical rotations in addition to longitudinal experiences in our outpatient infusion center, teaching, and clinical research.
As a respected cancer center and one of the founding members of the National Comprehensive Cancer Network (NCCN) PGY2 Oncology Pharmacy residents will have the opportunity to work on the forefront of patient care with nationally recognized practitioners. The resident will be integrally involved with health-care professionals throughout the continuum of patient care, including patient education, assessment, and therapeutic recommendations. Working with experienced pharmacy clinicians, the PGY2 pharmacy resident also will gain experience serving as a preceptor for pharmacy students and PGY1 pharmacy residents. Residents will provide compassionate, evidence-based, progressive medical care in both inpatient and outpatient settings. The program allows tailored instruction for the individual based on interest and past experiences.
Salary and Paid Time Off (PTO)
- PGY2 residents will receive a stipend of $43,680.
- Residents will be given 12 days for vacation and sick time during their 12-month program.
- Health insurance: comprehensive medical, dental and vision care coverage effective July 1.
- Basic life insurance and long term disability coverage.
- Residents will each receive one complimentary lab coat.
Funding for Professional Meetings
- Financial support will be provided to each resident attending the Fall Resident Retreat, ASHP’s Midyear Clinical Meeting, HOPA and the Midwest Pharmacist Residents Conference. Funding for additional meetings may be provided at the discretion of the director of Pharmaceutical and Nutrition Care.
The program provides the following days of required educational leave which are not deducted from the resident’s PTO allotment.
- Advanced Cardiac Life Support (ACLS) training and testing (two days in July if not already certified)
- Pediatric Advanced Life Support training and testing (optional) (two days)
- Resident Fall Retreat (two days)
- ASHP Midyear Clinical Meeting (four weekdays)
- HOPA Annual Conference (four weekdays)
- Midwest Pharmacists Residents Conference (two days)
Residents in all residency programs will be required to perform or participate in a number of activities throughout the year. These activities are designed to assure competency with the goals and objectives outlined in the Residency Learning System (RLS) and the ASHP accreditation standards. In addition to the expectations outlined in the accreditation standards, the residents are expected to be able to:
- Display professionalism on a daily basis
- Uphold and adhere to all standards of the pharmacy profession
- Demonstrate effective verbal and written communication skills
- Demonstrate the ability to educate, teach and lead other health care providers
- Demonstrate the ability to educate patients in regards to medication therapy
- Participate in quality improvement initiatives
The following specific activities are designed to achieve these outcomes and are required for successful completion of the program.
- Residents shall participate in the residency orientation program and all resident meetings
- Residents shall complete all service commitment required duties
- Residents shall complete all required and elective rotations
- Residents shall complete a research project designed to improve the services of the department and contribute knowledge to the pharmacy profession
- Residents shall participate in medication safety seminars
- Residents shall participate in the leadership development series if not already completed as a PGY1 resident
- Residents shall participate in the Oncology Journal Club
- Residents shall attend staff meetings
- Residents shall attend the Fall Resident Retreat
- Residents shall attend ASHP’s Midyear Clinical Meeting
- Residents shall attend 85 percent of Pharmacy Grand Rounds (PGR) seminars
- Residents shall prepare and present two ACPE-approved continuing education PGRs
- Residents shall participate in department service documentation activities
- Residents shall participate in recruitment efforts of the department
- Residents shall participate in the oncology residency conferences
- Residents shall participate in case conferences
- Residents shall participate in the teaching of P-4 pharmacy students on clinical rotations
- Residents shall participate in teaching activities at UNMC’s College of Pharmacy
- Residents shall successfully complete BLS and ACLS (PALS is optional)
- Residents shall present a poster at the UHC Midyear Meeting
- Residents shall present at the Midwest Pharmacy Residents Conference
- Residents shall complete a research project and research project manuscript
PGY2 residents are required to fulfill the service commitment (staffing) designed to ensure that residents gain experience and can function as competent clinical oncology practitioners. Each resident will train with preceptors and basic training will take place during the first month of residency. At the conclusion of the basic training period, the designated preceptors and the resident will mutually determine if the resident is ready to function independently as a pharmacist.
As part of the service commitment for PGY2 residents, the following staffing requirements apply:
- PGY2 residents will staff 22 shifts throughout the year, approximately two shifts per month that may or may not include weekends and/or evenings.
- PGY2 residents must work one holiday.
- Staffing will occur primarily in the resident’s specialty area of training.
Residents are required to develop and complete a research project. Residents will select a research topic based on their clinical interests. Faculty and clinical staff will present project ideas during orientation. An appropriate preceptor will be selected to guide and supervise the resident. Residents will develop a formal research proposal. If necessary, the resident will submit the proposal for IRB approval. A completed research project form, formal proposal, completed IRB (if required), oral presentation at the Midwest Pharmacy Residency Conference and final written manuscript are required for successful completion of the project.
Poster Presentation at University HealthSystem Consortium
Each resident will present a poster on their research topic at the University HealthSystem Consortium (UHC) meeting held in conjunction with the ASHP Midyear Clinical Meeting.
Attendance/Presentation at the Midwest Pharmacy Residents Conference (MPRC)
Each resident is required to attend and present research findings at the MPRC held each spring. Each resident will make a brief presentation on their project which will be evaluated by a preceptor from within or outside of the program.
- Orientation (July)
- Research (December)
- Stem Cell Transplant - two months
- General Oncology - two months
- Pediatric Hematology/Oncology
- Gynecology Oncology
- Ambulatory Oncology Clinics
- Village Pointe Infusion Centers
- Oncology Pharmacy Management
- Clinical Decision Support
- Pharmacy Grand Rounds
- Leadership Development Series - if not already completed as a PGY1
- Oncology Residency Conference
- Service (Staffing)
- Infectious Disease
- Oncology Infectious Diseases service
- Pain Management/Palliative Care
- Radiation Oncology
- Surgical Oncology
Nebraska Medicine is the clinical partner of the University of Nebraska Medical Center (UNMC), which includes the colleges of medicine, pharmacy, nursing, dentistry and allied health. UNMC, with an enrollment of approximately 3,655 students, is the only public academic health science center in Nebraska and is internationally recognized as a leader in patient care, research and education. The not-for-profit hospital is known for excellence and innovation in medicine.
Nebraska Medicine is a 635-bed, level one trauma center with over 40,000 emergency room visits per year. As the primary teaching hospital for UNMC, Nebraska Medicine is a respected leader in solid organ transplantation, cardiology, bone marrow transplantation, oncology and neurosciences. Nebraska Medicine brings together the expertise of private practice medicine with the strengths of an academic health center.
Nebraska Medicine’s many areas of specialization give the resident a variety of experiences, from the critically ill neonate to the cancer patient undergoing transplantation. By combining state-of-the-art research, education and extraordinary patient care, we offer the best of both worlds.
The working relationship between Nebraska Medicine and the UNMC College of Pharmacy provides a solid foundation for a quality pharmacy residency program. The program provides an excellent mixture of clinical experiences, one-on-one interaction with faculty and clinical preceptors and the flexibility to modify the program to individual needs. In addition, the residency provides many opportunities for educating and precepting students. The end product is pharmacy training that actively involves the resident in patient care, education and research.
Qualifications for participation in Nebraska Medicine PGY2 Residency Program are in accordance with criteria set forth by the American Society of Health-System Pharmacists (ASHP).
- Resident applicants shall be graduates of an Accreditation Council for Pharmacy Education (ACPE)-accredited doctor of pharmacy degree program
- Residents shall have completed an accredited PGY1 pharmacy residency program
- Resident applicants must be licensed or eligible for licensure as a pharmacist in the state of Nebraska
- Licensure must be obtained by July 31
- Resident applicants shall participate and adhere to all rules of the ASHP Resident Matching Program process
Candidates are required to complete and submit an online electronic application through PhORCAS. No hardcopy applications will be accepted. Please review the application agreement below to proceed to the PhORCAS website. Deadline January 3.
Required application materials include the following:
- letter of intent (addressing program specific questions)
- curriculum vitae
- pharmacy school transcripts
- three narrative letters of recommendation in addition to PhORCAS standardized reference forms
Program specific application information for PhORCAS are as follows:
Letter of Intent
A one page letter of intent addressed to Dr. Susanne Liewer. In this letter, please address the following three statements:
- Why would you like to pursue a residency at Nebraska Medicine?
- Why are you choosing to complete a pharmacy residency and how do you feel this experience will influence your career?
- Describe one situation in which you influenced a patient’s medical therapy.
Your curriculum vitae must include (if applicable) a minimum of:
- Work experience
- Leadership experience
- Organizational involvement and positions held
- Philanthropy/community service
- Research experience/publications
- Rotational experiences
Three Letters of Recommendation
- Three narrative letters are required along with standardized PhORCAS reference forms.
- Two of the letters of recommendation must be from clinical preceptors who can attest to your abilities as a pharmacy professional, commenting on your character, personality, dependability, professionalism and clinical abilities.
After receipt of all application materials above, applicants will be reviewed and a select number of candidates will be invited for a required onsite interview.
The applicant applying through the Pharmacy Online Residency Application Service (PhORCAS) acknowledges and agrees to the following:
I certify that the information contained in the PhORCAS application is true to the best of my knowledge and belief. I understand that any omission of facts or misrepresentation is cause for denial of employment and/or dismissal (if hired) regardless of when discovered.
I grant permission for the authorities of Nebraska Medicine to investigate my work references and release them and any former employer from any and all liability resulting from such investigation. Upon my termination, I authorize the release of reference information on my work.
I agree to submit to a post-offer physical, including drug and/or alcohol screening and recognize employment is contingent upon successfully meeting physical requirements.
I further agree that if I’ve been convicted of a crime, the authorities of Nebraska Medicine may obtain the details of my conviction to determine its relationship to the position I’m applying for as a condition of my employment.
In consideration of my employment, I agree to conform to the rules and regulations of Nebraska Medicine. My employment may be terminated, with or without cause, at any time, at the option of Nebraska Medicine or myself. I certify that the information submitted in this application is complete and correct to the best of my knowledge and belief. I grant Nebraska Medicine permission, if necessary, to request additional information from previous schools and employers concerning my academic record and professional ability.
You will be required to obtain a Nebraska license by July 31.
Federal law requires evidence of identity and employment eligibility upon hire.
Nebraska Medicine is an EOE/AA Employer
Susanne Liewer, PharmD, BCOP
PGY2 Oncology Residency Program Director
981090 Nebraska Medical Center
Omaha, NE 68198-1090
Email Susanne Liewer